Last update 23 Jan 2025

Qualicaps Netherlands BV

Private Company|
1992|
Netherlands

Overview

Tags

Urogenital Diseases
Hemic and Lymphatic Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
TPO receptor(Thrombopoietin receptor)1
PBPs(Bacterial penicillin-binding protein)1
ER(Estrogen receptors)1

Related

3
Drugs associated with Qualicaps Netherlands BV
Cefiderocol Sulfate Tosylate
Target
PBPs
Mechanism
PBPs inhibitors
Active Org.
Shionogi, Inc. [+5]
Originator Org.
Shionogi & Co., Ltd.Shionogi & Co., Ltd.
Active Indication
Infectious Diseases [+15]
Inactive Indication
Acute pyelonephritis
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date14 Nov 2019
Lusutrombopag
Target
TPO receptor
Mechanism
TPO receptor agonists
Active Org.
Shionogi, Inc. [+4]
Originator Org.
Shionogi & Co., Ltd.Shionogi & Co., Ltd.
Active Indication
Thrombocytopenia
Inactive Indication
Chronic liver disease [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date28 Sep 2015
Ospemifene
Target
ER
Mechanism
ERs modulators
Active Org.
Duchesnay, Inc.Duchesnay, Inc. [+1]
Originator Org.
Shionogi & Co., Ltd.Shionogi & Co., Ltd.
Active Indication
vaginal mucosa dry [+2]
Inactive Indication
Atrophy
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date26 Feb 2013
3
Clinical Trials associated with Qualicaps Netherlands BV
ISRCTN12615820
/ CompletedPhase 1
Phase I Trial, Quotient Code: QSC207970 [The full scientific title will be published within 30 months after the end of the trial]
JPRN-jRCT1080225285
/ CompletedPhase 1
A Phase I Study to Investigate the Absorption, Distribution, Metabolism and Excretion of [14C]-S-600918 Following Oral Dose Administration in Healthy Adult Male Subjects
JPRN-JapicCTI-205381
/ CompletedPhase 1
A Phase I Study to Investigate the Absorption, Distribution, Metabolism and Excretion of [14C]-S-600918 Following Oral Dose Administration in Healthy Adult Male Subjects
100 Clinical Results associated with Qualicaps Netherlands BV
Login to view more data
0 Patents (Medical) associated with Qualicaps Netherlands BV
Login to view more data
100 Deals associated with Qualicaps Netherlands BV
Login to view more data
100 Translational Medicine associated with Qualicaps Netherlands BV
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Lusutrombopag
 ( TPO receptor )		Thrombocytopenia
More
Approved
Cefiderocol Sulfate Tosylate
 ( PBPs )		Gram-Negative Bacterial Infections
More
Approved
Ospemifene
 ( ER )		Vulvovaginal atrophy
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free